ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | ||
| Net Income | -3,437 | -1,406 |
| Depreciation Amortization | 99 | 91 |
| Other Working Capital | 72 | -531 |
| Other Operating Activity | 117 | 58 |
| Operating Cash Flow | $-3,150 | $-1,788 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -43 | -4 |
| Investing Cash Flow | $-43 | $-4 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 500 | N/A |
| Common Stock Issued | 30 | 4,225 |
| Financing Cash Flow | $530 | $4,225 |
| Beginning Cash Position | 5,275 | 2,841 |
| End Cash Position | 2,612 | 5,275 |
| Net Cash Flow | $-2,663 | $2,433 |
| Free Cash Flow | ||
| Operating Cash Flow | -3,150 | -1,788 |
| Capital Expenditure | -43 | -4 |
| Free Cash Flow | -3,193 | -1,792 |